Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 15:28 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- AED 18.36T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | AED 18.3B | AED 52.12 | 3.12% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | AED 34.7B | AED 365.33 | 1.96% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | AED 24.8B | AED 365.66 | 3.99% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | AED 19.6B | AED 463.83 | 1.14% up | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | AED 14.6B | AED 106.69 | 0.24% down | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | AED 27.3B | AED 347.94 | 0.33% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | AED 37B | AED 244.63 | 0.73% up | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | AED 17.8B | AED 316.23 | 2.52% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | AED 84.4B | AED 73.62 | 1.16% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | AED 105.1B | AED 145.11 | 2.01% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | AED 27.7B | AED 79.55 | 1.01% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | AED 32.7B | AED 1,170.37 | 4.41% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | AED 16.5B | AED 150.95 | 0.65% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | AED 144.5B | AED 251.37 | 0.33% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | AED 172.3B | AED 147.68 | 4.78% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | AED 117.2B | AED 190.14 | 1.57% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | AED 28.8B | AED 171.48 | 0.34% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | AED 252.1B | AED 78.90 | 1.00% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | AED 30.7B | AED 470.32 | 0.70% up | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | AED 21.7B | AED 1,086.26 | 0.99% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | AED 1.22T | AED 495.79 | 2.02% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | AED 17.7B | AED 184.63 | 0.06% up | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | AED 23B | AED 567.48 | 1.10% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | AED 57.2B | AED 890.87 | 2.10% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | AED 2.36T | AED 982.33 | 1.92% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | AED 22.5B | AED 344.40 | 1.38% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | AED 4.46T | AED 5,003.35 | 1.48% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | AED 438.1B | AED 214.34 | 2.01% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | AED 64.8B | AED 988.13 | 0.48% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | AED 355.7B | AED 3,438.59 | 0.98% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | AED 495B | AED 1,952.46 | 0.90% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | AED 49.1B | AED 98.21 | 0.15% up | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | AED 1.05T | AED 557.86 | 2.14% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | AED 1.84T | AED 1,041.92 | 0.81% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | AED 88.5B | AED 2,077.48 | 2.03% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | AED 56.6B | AED 290.56 | 1.41% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | AED 30.2B | AED 435.70 | 0.34% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | AED 45.1B | AED 232.75 | 3.16% up | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | AED 169B | AED 1,479.53 | 0.19% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | AED 578.4B | AED 101.48 | 1.53% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | AED 23.1B | AED 163.35 | 3.17% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | AED 45.5B | AED 54.61 | 0.73% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | AED 354B | AED 176.62 | 1.01% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | AED 1T | AED 647.39 | 1.40% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | AED 20.8B | AED 30.60 | 1.64% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | AED 404.7B | AED 168.54 | 2.61% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | AED 26B | AED 494.07 | 0.39% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | AED 26.8B | AED 244.56 | 1.77% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | AED 666.5B | AED 384.84 | 0.29% up | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | AED 635.3B | AED 144.14 | 0.47% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | AED 26.5B | AED 190.41 | 1.02% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | AED 18.1B | AED 104.22 | 2.03% up | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | AED 18.6B | AED 222.31 | 0.50% up | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | AED 123.3B | AED 303.52 | 3.42% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | AED 34.2B | AED 1,471.53 | 0.65% up | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | AED 27.5B | AED 314.02 | 1.99% up | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | AED 31.2B | AED 39.06 | 1.29% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | AED 112.9B | AED 514.69 | 16.97% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | AED 11.3B | AED 58.32 | 2.28% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | AED 16.8B | AED 100.95 | 0.35% up | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | AED 73B | AED 545.21 | 0.64% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6728 AED).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 15:28 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of AED 18.36T as of 19 Nov 2026, 15:28 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.